Literature DB >> 16240453

Use of mononucleotide repeat markers for detection of microsatellite instability in mouse tumors.

Jeffery W Bacher1, Wael M Abdel Megid, Marijo G Kent-First, Richard B Halberg.   

Abstract

Tumors lacking DNA mismatch repair activity (MMR) from patients with Hereditary Nonpolyposis Colorectal Cancer (HNPCC) or those with sporadic colorectal cancer can be identified by the presence of high levels of instability in repetitive sequences known as microsatellites (MSI). The assessment of MSI phenotype in human tumors helps to establish a clinical diagnosis and is accomplished with a reference panel of five mononucleotide repeats. By contrast, detection of MSI in mouse tumors has proven to be problematic and lack of a uniform set of markers for classification of MSI has impeded comparison of results between studies. We tested for MSI in intestinal tumors from MMR-deficient mice with four mononucleotide repeats with polyA(24-37) tracts and three new markers with extended polyA(59-67) tracts. All seven markers were sensitive to MSI in MMR-deficient tumors, but those with extended mononucleotide tracts displayed larger deletions, which were easily distinguishable from the germline alleles. With a panel of the five most sensitive and specific mononucleotide repeats, a high level of MSI was detected in 100% of MMR-deficient tumors, but not in tumors with MMR activity. This novel panel is an improvement over existing combinations of mono- and dinucleotide repeat markers and should facilitate MSI screening and standardize results from different studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16240453     DOI: 10.1002/mc.20146

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  27 in total

1.  Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.

Authors:  Daniel J McGrail; Jeannine Garnett; Jun Yin; Hui Dai; David J H Shih; Truong Nguyen Anh Lam; Yang Li; Chaoyang Sun; Yongsheng Li; Rosemarie Schmandt; Ji Yuan Wu; Limei Hu; Yulong Liang; Guang Peng; Eric Jonasch; David Menter; Melinda S Yates; Scott Kopetz; Karen H Lu; Russell Broaddus; Gordon B Mills; Nidhi Sahni; Shiaw-Yih Lin
Journal:  Cancer Cell       Date:  2020-02-27       Impact factor: 31.743

2.  Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.

Authors:  Erin M Coffee; Anthony C Faber; Jatin Roper; Mark J Sinnamon; Gautam Goel; Lily Keung; Wei Vivian Wang; Loredana Vecchione; Veerle de Vriendt; Barbara J Weinstein; Roderick T Bronson; Sabine Tejpar; Ramnik J Xavier; Jeffrey A Engelman; Eric S Martin; Kenneth E Hung
Journal:  Clin Cancer Res       Date:  2013-04-02       Impact factor: 12.531

3.  Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.

Authors:  Daniel L Worthley; Susan L Woods; Tamsin R M Lannagan; Young K Lee; Tongtong Wang; Jatin Roper; Mark L Bettington; Lochlan Fennell; Laura Vrbanac; Lisa Jonavicius; Roshini Somashekar; Krystyna Gieniec; Miao Yang; Jia Q Ng; Nobumi Suzuki; Mari Ichinose; Josephine A Wright; Hiroki Kobayashi; Tracey L Putoczki; Yoku Hayakawa; Simon J Leedham; Helen E Abud; Ömer H Yilmaz; Julie Marker; Sonja Klebe; Pratyaksha Wirapati; Siddhartha Mukherjee; Sabine Tejpar; Barbara A Leggett; Vicki L J Whitehall
Journal:  Gut       Date:  2018-04-17       Impact factor: 23.059

4.  Msh6 protects mature B cells from lymphoma by preserving genomic stability.

Authors:  Jonathan U Peled; Rani S Sellers; Maria D Iglesias-Ussel; Dong-Mi Shin; Cristina Montagna; Chunfang Zhao; Ziqiang Li; Winfried Edelmann; Herbert C Morse; Matthew D Scharff
Journal:  Am J Pathol       Date:  2010-10-07       Impact factor: 4.307

5.  PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

Authors:  D A Deming; A A Leystra; L Nettekoven; C Sievers; D Miller; M Middlebrooks; L Clipson; D Albrecht; J Bacher; M K Washington; J Weichert; R B Halberg
Journal:  Oncogene       Date:  2013-05-27       Impact factor: 9.867

6.  Molecular characterisation of murine acute myeloid leukaemia induced by 56Fe ion and 137Cs gamma ray irradiation.

Authors:  Leta S Steffen; Jeffery W Bacher; Yuanlin Peng; Phuong N Le; Liang-Hao Ding; Paula C Genik; F Andrew Ray; Joel S Bedford; Christina M Fallgren; Susan M Bailey; Robert L Ullrich; Michael M Weil; Michael D Story
Journal:  Mutagenesis       Date:  2012-09-17       Impact factor: 3.000

7.  ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.

Authors:  Carl Koschmann; Anda-Alexandra Calinescu; Felipe J Nunez; Alan Mackay; Janet Fazal-Salom; Daniel Thomas; Flor Mendez; Neha Kamran; Marta Dzaman; Lakshman Mulpuri; Johnathon Krasinkiewicz; Robert Doherty; Rosemary Lemons; Jacqueline A Brosnan-Cashman; Youping Li; Soyeon Roh; Lili Zhao; Henry Appelman; David Ferguson; Vera Gorbunova; Alan Meeker; Chris Jones; Pedro R Lowenstein; Maria G Castro
Journal:  Sci Transl Med       Date:  2016-03-02       Impact factor: 17.956

8.  Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases.

Authors:  Arne Warth; Sandrina Körner; Roland Penzel; Thomas Muley; Hendrik Dienemann; Peter Schirmacher; Magnus von Knebel-Doeberitz; Wilko Weichert; Matthias Kloor
Journal:  Virchows Arch       Date:  2015-12-04       Impact factor: 4.064

9.  Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway.

Authors:  Richard B Halberg; Jesse Waggoner; Kristen Rasmussen; Alanna White; Linda Clipson; Amy J Prunuske; Jeffery W Bacher; Ruth Sullivan; Mary Kay Washington; Henry C Pitot; John H J Petrini; Donna G Albertson; William F Dove
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

10.  PeakSeeker: a program for interpreting genotypes of mononucleotide repeats.

Authors:  James M Thompson; Stephen J Salipante
Journal:  BMC Res Notes       Date:  2009-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.